Montelukast Sodium Tablet, Film Coated
Product Images NDC 43063-762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 43063-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (43063762)

Image (43063762)
This is a description of a medicine package that contains Montelukast Sodium USP in the form of tablets. The strength of each tablet is 10 mg and the package contains a total of 30 tablets. The lot number of the package is A21F04 and the expiration date is 01/2023. The package insert should be consulted for information about dosage and storage. It warns the user to keep the medicine out of reach of children. It also advises that medical advice should be taken in case of any side effects and that side effects can be reported to FDA at the provided number. The text contains a barcode (NDC) and some other references, but they do not provide any additional useful information.*
FDA Label Image

Image Of Figure 1 (Montelukast Fig1)

Image Of Figure 1 (Montelukast Fig1)
Mean percent change from baseline for an unknown variable was measured at weeks 3, 9, 12, and 15 during treatment with Montelukast Sodium Tablets. There is some unclear text and characters in the description.*
FDA Label Image

Image Of Chemical Structure (Montelukast Str)

Image Of Chemical Structure (Montelukast Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.